Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
6th European Breast Cancer Conference
Managing Endocrine-responsive, Early Breast Cancer
Berlin, Germany / April 15-19, 2008
Berlin - Experts here confirmed that determining endocrine responsiveness is of primary importance as a first approach to choosing systemic therapy for postmenopausal women with early breast cancer and estrogen receptor-positive tumour....
XXIIIrd Annual Congress of the European Association of Urology
CombAT and Prostate Health: Combination Strategies for Long-term Efficacy
Milan, Italy / March 26-29, 2008
Milan - The combination of an alpha blocker to relieve symptoms and improve flow plus a 5a-reductase inhibitor (5ARI) to reduce prostate volume is a rational strategy for men with lower urinary tract symptoms secondary to benign prostatic...
6th World Congress on the Aging Male
The Role of 5-Alpha Reductase Inhibition in Prostate Cancer and BPH: Lessons From Clinical Trials
Tampa, Florida / February 21-24, 2008
Tampa - In the 1990s, widespread acceptance of the prostate-specific antigen (PSA) assay led to a sharp increase in the detection and subsequent treatment of prostate cancer. The advent of PSA testing coincided with the introduction of the...
MEDICAL FRONTIERS - 2008 Gastrointestinal Cancers Symposium
Gastrointestinal Stromal Tumours and Tyrosine Kinase Inhibitors: New Strategies to Reduce the Risk of Recurrence
Orlando, Florida / January 25-27, 2008
Prior to the era of the tyrosine kinase inhibitors (TKIs), slightly over half of patients with primary gastrointestinal stromal tumours (GIST) without metastatic disease would still be alive five years after surgery. This indicated that...
30th Annual San Antonio Breast Cancer Symposium
Improving Treatment Outcomes in HER2-positive Breast Cancer
San Antonio, Texas / December 13-16, 2007
San Antonio - Approximately 20% to 30% of breast cancers exhibit overexpression of human epidermal growth factor receptor 2 (HER2), a cell surface protein involved in the regulation of cell growth and division. HER2 activation in cancer...
30th Annual San Antonio Breast Cancer Symposium
Issues in Endocrine Therapy for Early-stage Breast Cancer
San Antonio, Texas / December 13-16, 2007
San Antonio - Hormonal therapy has a long history of efficacy in the treatment of breast cancer. Tamoxifen represented a breakthrough in management of breast cancer, demonstrating in several large clinical trials the ability to reduce the...
49th Annual Meeting and Exposition of the American Society of Hematology
Less Toxic Broad-Spectrum Antifungals: Facilitating Infection Control in Hematological Malignancies
Atlanta, Georgia / December 8-11, 2007
Atlanta - The substantial morbidity and mortality imposed by invasive fungal infections in patients with hematological malignancies can be largely contained by a high index of suspicion and early use of broad-spectrum antifungal drugs....
49th Annual Meeting and Exposition of the American Society of Hematology
From First-line to Consolidation Therapies: Exploring Options in Hematologic Malignancies
Atlanta, Georgia / December 8-11, 2007
Editorial Overview Joseph M. Connors, MD, ABIM, FRCPC Chair, Lymphoma Tumor Group BC Cancer Agency Clinical Professor of Medicine University of British Columbia Vancouver, British Columbia
49th Annual Meeting and Exposition of the American Society of Hematology
Treatment of Newly-diagnosed Multiple Myeloma Patients and the Role of Stem Cell Transplantation
Atlanta, Georgia / December 8-11, 2007
Atlanta - The standard of care is evolving rapidly in multiple myeloma (MM) due to a series of studies that have associated new treatment regimens with higher objective response rates and prolonged survival. These studies have been...